Cargando…

IL-4 inhibits regulatory T cells differentiation by HDAC9-mediated epigenetic regulation

Regulatory T cells play a crucial role in orchestrating immune response and maintaining immune tolerance, and the expression of the Foxp3 gene is indispensable to the differentiation of regulatory T cells. IL-4 shows strong inhibitory effects on Foxp3 expression and regulatory T cells differentiatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Jikai, Xu, Heng, Yu, Jizhang, Li, Yuan, Chen, Zhang, Zou, Yanqiang, Zhang, Xi, Du, Yifan, Xia, Jiahong, Wu, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131756/ https://www.ncbi.nlm.nih.gov/pubmed/34006836 http://dx.doi.org/10.1038/s41419-021-03769-7

Ejemplares similares

Targeting PCSK9 Ameliorates Graft Vascular Disease in Mice by Inhibiting NLRP3 Inflammasome Activation in Vascular Smooth Muscle Cells
por: Zou, Yanqiang, et al.
Publicado: (2022)

Single-Cell RNA sequencing reveals immune cell dynamics and local intercellular communication in acute murine cardiac allograft rejection
por: Chen, Zhang, et al.
Publicado: (2022)

Ablation of Survivin in T Cells Attenuates Acute Allograft Rejection after Murine Heterotopic Heart Transplantation by Inducing Apoptosis
por: Xu, Heng, et al.
Publicado: (2021)

Aspirin Attenuates Cardiac Allograft Rejection by Inhibiting the Maturation of Dendritic Cells via the NF-κB Signaling Pathway
por: Zhang, Xi, et al.
Publicado: (2021)

PLK1 Inhibition alleviates transplant-associated obliterative bronchiolitis by suppressing myofibroblast differentiation
por: Yu, Jizhang, et al.
Publicado: (2020)

Autophagy-lysosome inhibitor chloroquine prevents CTLA-4 degradation of T cells and attenuates acute rejection in murine skin and heart transplantation
por: Cui, Jikai, et al.
Publicado: (2020)

Autophagy-lysosome inhibitor chloroquine prevents CTLA-4 degradation of T cells and attenuates acute rejection in murine skin and heart transplantation: Erratum
por: Cui, Jikai, et al.
Publicado: (2022)

Increase in HDAC9 suppresses myoblast differentiation via epigenetic regulation of autophagy in hypoxia
por: Zhang, Zhang, et al.
Publicado: (2019)

HDAC9 is an epigenetic repressor of kidney angiotensinogen establishing a sex difference
por: Bourgeois, Camille T., et al.
Publicado: (2017)

Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites
por: Bougdour, Alexandre, et al.
Publicado: (2009)

Identification of HDAC9 as a viable therapeutic target for the treatment of gastric cancer
por: Xiong, Kai, et al.
Publicado: (2019)

HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation
por: Yang, Rui, et al.
Publicado: (2015)

The Transcription Factor NRF2 Has Epigenetic Regulatory Functions Modulating HDACs, DNMTs, and miRNA Biogenesis
por: Silva-Llanes, Ignacio, et al.
Publicado: (2023)

The Potential Role of Regulatory Genes (DNMT3A, HDAC5, and HDAC9) in Antipsychotic Treatment Response in South African Schizophrenia Patients
por: O’Connell, Kevin Sean, et al.
Publicado: (2019)

Epigenetics in Brain Tumors: HDACs Take Center Stage
por: Eyüpoglu, Ilker Y., et al.
Publicado: (2016)

Short communication: TNF-α and IGF-1 regulates epigenetic mechanisms of HDAC2 and HDAC10
por: Jiang, Wanlin, et al.
Publicado: (2022)

Specific Control of Pancreatic Endocrine β- and δ-Cell Mass by Class IIa Histone Deacetylases HDAC4, HDAC5, and HDAC9
por: Lenoir, Olivia, et al.
Publicado: (2011)

HDAC6 regulates IL-17 expression in T lymphocytes: implications for HDAC6-targeted therapies
por: Yan, Bing, et al.
Publicado: (2017)

Interaction between regulatory T cells and mast cells via IL-9 and TGF-β production
por: Zhao, Yi-Bin, et al.
Publicado: (2020)

PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors
por: Shi, Kaixuan, et al.
Publicado: (2019)

Epigenetic regulation of interleukin-8 expression by class I HDAC and CBP in ovarian cancer cells
por: Gatla, Himavanth R., et al.
Publicado: (2017)

Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure
por: Evans, Levi W., et al.
Publicado: (2018)

Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
por: Claveria-Cabello, Alex, et al.
Publicado: (2020)

Checkpoint regulator B7x is epigenetically regulated by HDAC3 and mediates resistance to HDAC inhibitors by reprogramming the tumor immune environment in colorectal cancer
por: Li, Yuxin, et al.
Publicado: (2020)

HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
por: Mayr, Christian, et al.
Publicado: (2021)

Knockout of HDAC9 Gene Enhances Foot-and-Mouth Disease Virus Replication
por: Hou, Shitong, et al.
Publicado: (2022)

HDAC mediated suppression of histone turnover promotes epigenetic stability of heterochromatin
por: Aygün, Ozan, et al.
Publicado: (2013)

An HDAC-dependent epigenetic mechanism that enhances the efficacy of the antidepressant drug fluoxetine
por: Schmauss, C.
Publicado: (2015)

Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells
por: Tay, Rong En, et al.
Publicado: (2020)

Determinants of epigenetic resistance to HDAC inhibitors in dystrophic fibro‐adipogenic progenitors
por: Consalvi, Silvia, et al.
Publicado: (2022)

Targeting Epigenetic Regulators with HDAC and BET Inhibitors to Modulate Muscle Wasting
por: Nevi, Lorenzo, et al.
Publicado: (2023)

Epigenetic master regulators HDAC1 and HDAC5 control pathobiont Enterobacteria colonization in ileal mucosa of Crohn’s disease patients
por: Chervy, Mélissa, et al.
Publicado: (2022)

Dissecting neural differentiation regulatory networks through epigenetic footprinting
por: Ziller, Michael J., et al.
Publicado: (2014)

HDAC1 Regulates Neuronal Differentiation
por: Nieto-Estevez, Vanesa, et al.
Publicado: (2022)

An HDAC9-associated immune-related signature predicts bladder cancer prognosis
por: Fu, Yang, et al.
Publicado: (2022)

Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma
por: Huang, Renhong, et al.
Publicado: (2018)

Preclinical and clinical progress for HDAC as a putative target for epigenetic remodeling and functionality of immune cells
por: Zhang, Sijia, et al.
Publicado: (2021)

Antibody drug conjugates (ADCs) charged with HDAC inhibitor for targeted epigenetic modulation
por: Cini, Elena, et al.
Publicado: (2018)

Correction: Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells
por: Tay, Rong En, et al.
Publicado: (2020)

Nuclear mechanosensing controls MSC osteogenic potential through HDAC epigenetic remodeling
por: Killaars, Anouk R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_65t4lv49e71uqcqv8jolrus0vs